Skip to content

Clinical trials

Phase 2 Bronchiolitis Obliterans Syndrome trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 2 Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20081
20091
20111
20121
20131
20152
20164
20181
20201
20212
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated5
Recruiting4
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Incyte Corporation3
AstraZeneca2
MetrioPharm AG2
Alexion Pharmaceuticals, Inc.1
Astellas Pharma Inc1
Celgene1
Charite University, Berlin, Germany1
ElectroCore INC1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome22
Chronic Urticaria2
Cluster Headache2
Psoriasis2
Pulmonary Disease, Chronic Obstructive2
Respiration Disorders2
Urticaria2
Arthritis, Reactive1
Bronchiolitis Obliterans1
Complex Regional Pain Syndromes1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.